We divided the HCC patients into the four groups of high-TGF-β1/high-TG2, high-TGF-β1/low-TG2, low-TGF-β1/high-TG2, and low-TGF-β1/low-TG2 (Figure 5A). Here, TGFB1 is linked to hepatocellular carcinoma.